Research Alliance III(NASDAQ) RACC

Research Alliance Corporation III helps companies join the stock market. It raises money to buy an existing, active business. This process lets businesses go public faster than usual.

Finding the Right Business

• Acquisition Search: Evaluating private businesses for a potential merger or share purchase.
• Capital Trust: Managing money in a secure account to pay for a future business deal.
• Transaction Management: Organizing the legal and financial steps to combine two companies.

A Roadmap for Expansion

• Signed a deal to merge with Oak Hill Bio, Inc. on July 26, 2026.
• Secured $55 million through a private investment in public equity to fund the deal.
• Established a $75 million backstop agreement to protect against investor withdrawals.
• Arranged $45 million in bridge financing for the target company at an 8% interest rate.

What Sets It Apart

The company holds $75,238,468 in a trust account to fund its first business merger. It plans to relocate its legal home from the Cayman Islands to Delaware following its next transaction.

Key Financial Facts

• Net income reached $54,050 for the three months ended June 30, 2026.
• Assets held in the trust account totaled $75,238,468 as of June 30, 2026.
• Cash on hand was $832,812 with working capital of $905,874 as of June 30, 2026.
• Offering costs for the initial public sale totaled $3,762,251 in May 2026.
• Interest income from inception through June 30, 2026, was $238,468.

Bottom Line

Research Alliance is currently a shell entity focused on completing its transition into a life sciences business through the Oak Hill Bio merger. It relies on its trust account and external financing to evolve into an operating corporation.